Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Fluid and Electrolyte Disturbances in Covid-19 and Their Complications Publisher Pubmed



Pourfridoni M1 ; Abbasnia SM1 ; Shafaei F1 ; Razaviyan J2 ; Heidarisoureshjani R3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran
  2. 2. Student Research Committee, Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Iran
  3. 3. Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: BioMed Research International Published:2021


Abstract

The novel coronavirus disease 2019 (COVID-19) is the cause of an acute respiratory illness which has spread around the world. The virus infects the host by binding to the angiotensin-converting enzyme 2 (ACE2) receptors. Due to the presence of ACE2 receptors in the kidneys and gastrointestinal (GI) tract, kidneys and GI tract damage arising from the virus can be seen in patients and can cause acute conditions such as acute kidney injury (AKI) and digestive problems for the patient. One of the complications of kidneys and GI involvement in COVID-19 is fluid and electrolyte disturbances. The most common ones of these disorders are hyponatremia, hypernatremia, hypokalemia, hypocalcemia, hypochloremia, hypervolemia, and hypovolemia, which if left untreated, cause many problems for patients and even increase mortality. Fluid and electrolyte disturbances are more common in hospitalized and intensive care patients. Children are also at greater risk for fluid and electrolyte disturbances complications. Therefore, clinicians should pay special attention to the fluid and electrolyte status of patients. Changes in fluid and electrolyte levels can be a good indicator of disease progression. © 2021 Mohammad Pourfridoni et al.
Other Related Docs
17. Critical Complications of Covid-19: A Descriptive Meta-Analysis Study, Reviews in Cardiovascular Medicine (2020)
22. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
23. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
30. Being a Front-Line Dentist During the Covid-19 Pandemic: A Literature Review, Maxillofacial Plastic and Reconstructive Surgery (2020)
33. Crispr/Cas13: A Potential Therapeutic Option of Covid-19, Biomedicine and Pharmacotherapy (2020)
39. Dental Care Management During the Covid-19 Outbreak, Special Care in Dentistry (2020)
40. Analyzing Trends in Demographic, Laboratory, Imaging, and Clinical Outcomes of Icu-Hospitalized Covid-19 Patients, Canadian Journal of Infectious Diseases and Medical Microbiology (2023)
47. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
49. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)